Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

580 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expansion of the CRF19_cpx Variant in Spain.
Patiño Galindo JA, Torres-Puente M, Gimeno C, Ortega E, Navarro D, Galindo MJ, Navarro L, Navarro V, Juan A, Belda J, Bracho MA, González-Candelas F; CRIVIH. Patiño Galindo JA, et al. Among authors: navarro l, navarro v, navarro d. J Clin Virol. 2015 Aug;69:146-9. doi: 10.1016/j.jcv.2015.06.094. Epub 2015 Jun 23. J Clin Virol. 2015. PMID: 26209397
Preservation of anti-SARS-CoV-2 neutralising antibodies in convalescent plasma after pathogen reduction with methylene blue and visible light.
Larrea L, Castro E, Navarro L, Vera B, Francés-Gómez C, Sánchez-Sendra B, Giménez Á, Castelló E, Collado M, Vayá MJ, Mirabet V, Callao V, Ortiz-de-Salazar MI, Roig R, Geller R, Arbona C. Larrea L, et al. Among authors: navarro l. Blood Transfus. 2022 May;20(3):206-212. doi: 10.2450/2021.0136-21. Epub 2021 Aug 2. Blood Transfus. 2022. PMID: 34369870 Free PMC article.
Transfusion-transmitted arboviruses: Update and systematic review.
Giménez-Richarte Á, Ortiz de Salazar MI, Giménez-Richarte MP, Collado M, Fernández PL, Clavijo C, Navarro L, Arbona C, Marco P, Ramos-Rincon JM. Giménez-Richarte Á, et al. Among authors: navarro l. PLoS Negl Trop Dis. 2022 Oct 6;16(10):e0010843. doi: 10.1371/journal.pntd.0010843. eCollection 2022 Oct. PLoS Negl Trop Dis. 2022. PMID: 36201547 Free PMC article.
Massive amorphous mass in apheresis platelet product.
Larrea L, Vera B, Gómez I, Navarro L, Castro E, Arbona C. Larrea L, et al. Among authors: navarro l. Transfusion. 2021 Dec;61(12):3293-3294. doi: 10.1111/trf.16720. Epub 2021 Nov 2. Transfusion. 2021. PMID: 34726273 No abstract available.
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab.
Toboso I, Tejeda-Velarde A, Alvarez-Lafuente R, Arroyo R, Hegen H, Deisenhammer F, Sainz de la Maza S, Alvarez-Cermeño JC, Izquierdo G, Paramo D, Oliva P, Casanova B, Agüera-Morales E, Franciotta D, Gastaldi M, Fernández O, Urbaneja P, Garcia-Dominguez JM, Romero F, Laroni A, Uccelli A, Perez-Sempere A, Saiz A, Blanco Y, Galimberti D, Scarpini E, Espejo C, Montalban X, Rasche L, Paul F, González I, Álvarez E, Ramo C, Caminero AB, Aladro Y, Calles C, Eguía P, Belenguer-Benavides A, Ramió-Torrentà L, Quintana E, Martínez-Rodríguez JE, Oterino A, López de Silanes C, Casanova LI, Landete L, Frederiksen J, Bsteh G, Mulero P, Comabella M, Hernández MA, Espiño M, Prieto JM, Pérez D, Otano M, Padilla F, García-Merino JA, Navarro L, Muriel A, Frossard LC, Villar LM. Toboso I, et al. Among authors: navarro l. Front Neurol. 2020 Dec 17;11:579438. doi: 10.3389/fneur.2020.579438. eCollection 2020. Front Neurol. 2020. PMID: 33408681 Free PMC article.
Pathogen inactivation of platelet concentrates.
Reesink HW, Panzer S, McQuilten ZK, Wood EM, Marks DC, Wendel S, Trigo F, Biagini S, Olyntho S, Devine DV, Mumford I, Cazenave JP, Rasonglès P, Garraud O, Richard P, Schooneman F, Vezon G, Al Radwan R, Brand A, Hervig T, Castro E, Lozano M, Navarro L, Puig L, Almazán C, MacLennan S, Cardigan R, Franklin IM, Prowse C. Reesink HW, et al. Among authors: navarro l. Vox Sang. 2010 Jul 1;99(1):85-95. doi: 10.1111/j.1423-0410.2010.01319.x. Epub 2010 Mar 10. Vox Sang. 2010. PMID: 20230599 No abstract available.
Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab.
Villar LM, Costa-Frossard L, Masterman T, Fernandez O, Montalban X, Casanova B, Izquierdo G, Coret F, Tumani H, Saiz A, Arroyo R, Fink K, Leyva L, Espejo C, Simó-Castelló M, García-Sánchez MI, Lauda F, Llufriú S, Álvarez-Lafuente R, Olascoaga J, Prada A, Oterino A, de Andrés C, Tintoré M, Ramió-Torrentà L, Rodríguez-Martín E, Picón C, Comabella M, Quintana E, Agüera E, Díaz S, Fernandez-Bolaños R, García-Merino JA, Landete L, Menéndez-González M, Navarro L, Pérez D, Sánchez-López F, Serrano-Castro PJ, Tuñón A, Espiño M, Muriel A, Bar-Or A, Álvarez-Cermeño JC. Villar LM, et al. Among authors: navarro l. Ann Neurol. 2015 Mar;77(3):447-57. doi: 10.1002/ana.24345. Epub 2015 Jan 30. Ann Neurol. 2015. PMID: 25581547
580 results